Objectives. To investigate the mechanism of 2-methoxyestradiol (2-ME) in inhibiting hypoxia-induced collagen synthesis of fibroblasts in SSc.
Introduction
SSc, also called scleroderma, is a heterogeneous CTD of unknown aetiology. The distinguishing hallmark of SSc is characterized by the pathologic remodelling of connective tissues in skin and internal organs [1] . Currently, there is still no cure for SSc, and the possibility of modifying or reversing tissue fibrosis remains very low [2] .
RP, occurring early in almost all SSc patients, suggests decreased blood flow and tissue hypoxia [3] . Hypoxia activates fibroblasts and up-regulates the fibrotic cytokine connective tissue growth factor (CTGF) and the production of extracellular matrix, especially collagen I [4] . Hypoxia-inducible factor 1 alpha (HIF-1a) is a crucial transcription factor in hypoxia signalling [5] . Analysis of embryonic fibroblasts derived from HIF-1a À/À mice has illustrated that the induction of collagen I under hypoxic conditions is mainly mediated by HIF-1a [6] . In the advanced disease stage of SSc, excessive deposition of collagen in tissue increases diffusion distances from blood vessels to cells, leading to aggravated tissue hypoxia [7] . In summary, hypoxia plays a crucial role in the onset and progression of SSc. Therefore, HIF-1a-mediated hypoxia pathways may be a novel target for the treatment of SSc and other fibrotic diseases [8] .
As a potent inhibitor of HIF-1a, 2-methoxyestradiol (2-ME) is a natural endogenous metabolite of 17b-estradiol [9] . 2-ME has no side effect of estradiol, and it is orally available and well-tolerated [10] . Our previous study revealed that 2-ME suppresses fibrosis in murine SSc by inhibiting collagen production and enhancing collagen degradation of fibroblasts [11] . However, it remains unclear how 2-ME inhibits the activation of fibroblasts induced by hypoxia. In the present study, we aimed to investigate the mechanism of 2-ME in inhibiting hypoxiainduced collagen synthesis of fibroblasts in SSc.
Methods

Patients and skin biopsy
Full-thickness (7 mm) skin biopsies of about 50 mm 2 in size were collected from the forearm lesions of three patients who met the ACR/EULAR criteria for SSc [12] , and normal skins were obtained from three age-and sexmatched healthy volunteers. The study was reviewed and approved by the Research Ethics Committee of Zhongshan Hospital, Fudan University and informed consents were obtained from all participants.
Immunohistochemistry
Immunohistochemistry of dermal specimens was performed as previously described [11] , and antibodies against HIF-1a or CTGF were purchased from Abcam, UK. Images were acquired with a microscope equipped with a digital camera (Leica, Germany). The numbers of positive cells and total cells were counted by two independent examiners. Staining for each sample was performed at least three times.
Cell culture and induction of hypoxia Primary fibroblasts were cultured according to the method described in our previous study [13] and maintained in DMEM supplemented with 10% fetal bovine serum. Fibroblasts cultured under standard conditions (37 C, 5% CO 2 , 21% O 2 ) were used for analysis at early passage [38] . For hypoxic exposure, fibroblasts were transferred into a hypoxic incubator (Thermo Fisher Scientific, USA) containing 5% CO 2 and 1% O 2 .
Western-blotting analysis Cells were lysed in radioimmunoprecipitation assay buffer (Beyotime Biotechnology, China) containing phenylmethylsulfonyl fluoride and phosphatase inhibitor cocktail (Thermo Fisher Scientific, USA). Equal amounts of proteins (30 mg) were resolved in 10% SDSPAGE and transferred onto polyvinylidene fluoride membranes. Membranes were blocked with tris-buffered saline and tween solution (0.1% Tween-20 in TBS) containing 5% BSA at room temperature to block non-specific bindings and then incubated with primary antibodies against HIF1a, CTGF, collagen I (all from Abcam, UK), p-Akt(Ser473), p-Akt(Thr308), p-mTOR(Ser2448) and b-actin (all from Cell Signaling Technology, USA) at 4 C overnight. Subsequently, the blots were incubated with horseradish peroxidase-conjugated secondary antibody for 2 h. Immunoreactive bands were visualized with electrochemiluminescence reagents (Millipore, USA). Quantitative determination of protein levels was performed based on imaging densitometry using Image J (NIH, USA). The experiments were performed at least three times.
Immunofluorescence staining
Dermal fibroblasts were seeded at a density of 3 Â 10 4 /ml and cultured under normoxic condition for 24 h. Subsequently, cells were incubated under hypoxic condition for 0, 6, 12 and 24 h. Fibroblasts were fixed with 4% paraformaldehyde for 30 min and permeabilized by 0.1% Triton X-100 (Sigma, USA) at room temperature for 30 min. Cells were blocked with PBS containing 5% fetal bovine serum for 30 min and incubated with antibodies specific to HIF-1a, CTGF or collagen I overnight. All dishes were washed three times and then incubated with corresponding secondary antibodies at room temperature for an additional 2 h. The slides were counterstained with 4',6-diamidino-2-phenylindole for 10 min to visualize the nuclei and then photographed under an immunofluorescence microscope (Olympus, Japan).
Stimulation with LY294002, rapamycin and 2-ME Dermal fibroblasts were grown in 100-mm culture dishes to 6070% confluence and pretreated with 10 mM LY294002 (MedChemExpress, USA), 50 nM rapamycin (Millipore, USA) or/and 25 mM 2-ME (MCE, USA) for 1 h.
Inhibition of HIF-1a by RNA interference Lentiviral transduction particles carrying short hairpin RNA sequence against human HIF-1a (5 0 -CCTAATAGTCCCAG TGAAT-3 0 ) or control non-target (shCon) sequence (5 0 -GT AGCGCGGTGTATTATAC-3 0 ) were used to knockdown HIF-1a expression in SSc and normal fibroblasts. Cells were seeded in six-well plates and incubated with lentiviral particles carrying HIF-1a short hairpin RNA or control particles at the multiplicity of infection of five in the presence of polybrene (10 mg/ml) for 12 h. Transfected cells were analysed for HIF-1a expression after 24-h exposure to hypoxia.
Cell apoptosis/cycle assay
Fibroblasts were seeded in 100-mm culture dishes and grown to 6070% confluence, and then the cells were treated with 25 mM 2-ME or not under hypoxic condition for 24 h. Control cells were maintained under normoxic condition for 24 h. In order to assess the cell apoptosis, 1 Â 10 6 cells were harvested from each dish, resuspended in 100 ml Annexin V binding buffer and then stained with 5 ml 7-amino-actinomycin and 5 ml APC-Annexin V staining solutions (BD Biosciences, USA). Cells were incubated in the dark at room temperature for 15 min, and the data were then acquired through a FACS Calibur flow cytometer (BD Biosciences). In addition, the caspase 3 activity of the above-mentioned cells was measured using a caspase 3 activity assay kit (Beyotime, China) according to the manufacturer's instructions. The absorbance was read at 405 nm with a microplate reader (Bio-Rad, USA).
For cell cycle analysis, 1 Â 10 6 cells were harvested from each dish, washed with PBS and subjected to centrifugation. Subsequently, cell pellet was resuspended in 10 ml permeabilization solution and then incubated in 1 ml DNA staining solution (Multi Sciences, China) in the dark for 30 min. The DNA content was analysed by a flow cytometer. Data were analysed using the FlowJo X.0.7 software (Stanford University, USA). Each independent experiment was carried out at least three times.
Cell proliferation assay
Fibroblasts were firstly seeded at a density of 3000 cells per well in 96-well microplates and cultured overnight under normoxic condition. Cells were then incubated with fresh medium in the presence or absence of 25 mM 2-ME. After 0, 24, 48 or 72 h of incubation under hypoxic or normoxic conditions, cells in each well were treated with 10 ml Cell Counting Kit-8 (Dojindo, Japan) and further incubated at 37 C for 1 h. The optical density at a wavelength of 450 nm was determined with a microplate reader (Bio-Rad, USA). All experiments were carried out three times.
Statistical analysis
Results were expressed as means (S.D.). All analyses were carried out using SPSS 14.0 software. Differences among groups were assessed by one-way ANOVA, and P < 0.05 was considered as statistically significant.
Results
Expressions of HIF-1a and CTGF at the protein level in SSc skin biopsies Signals for HIF-1a were detected in skin specimens from both SSc patients and healthy volunteers (Fig. 1A and B) . The nuclear staining of HIF-1a was observed in the epidermis of both SSc patients and healthy controls with no significant difference. In the dermis, we found several signals for HIF-1a from SSc patients, while no obvious signals were observed from healthy controls (P < 0.05). In addition, strong cytoplasmic signals of CTGF were detected throughout the epidermis and dermis of SSc patients, whereas only weak signals were observed in those of healthy controls (P < 0.05) (Fig. 1C and D) .
Hypoxia-induced expressions of HIF-1a, CTGF and collagen I in dermal fibroblasts https://academic.oup.com/rheumatology (P < 0.01), CTGF (P < 0.05) and collagen I (P < 0.01) were all detected at 24 h under hypoxic conditions ( Fig. 2A) . Similar protein accumulations of HIF-1a, CTGF and collagen I could be observed by immunofluorescence staining (Fig. 2B) . There was no significant difference between fibroblasts from SSc patients and health controls (data not shown). Therefore, these results indicated that hypoxia increased the expressions of HIF-1a and its downstream targets CTGF and collagen I in both SSc and normal fibroblasts.
Hypoxia-induced activation of PI3K/Akt/mTOR in dermal fibroblasts Figure 3A shows that even a short-term exposure to hypoxia (030 min) could exert a remarkable effect on the phosphorylation of Akt and mTOR in SSc fibroblasts. The induction of Akt phosphorylation occurred at Thr308 and Ser473 positions and mTOR phosphorylation at Ser2448 position. The hypoxia-aggravated phosphorylation of Akt and mTOR was inhibited by LY294002, a PI3K inhibitor (P < 0.01) [ Fig. 3(B1)(B3) 
The protein levels of HIF-1a (A1), CTGF (A2) and collagen I (A3) were measured by western blotting analysis after fibroblasts were cultured under hypoxic condition for 0, 6, 12 or 24 h. (B) Immunofluorescence staining of HIF-1a, CTGF and collagen I of fibroblasts cultured under hypoxic condition for 0, 6, 12 or 24 h. Values are presented as mean (S.D.) (n 5 3). *P< 0.05, **P < 0.01.
FIG. 3 Effects of LY294002 and rapamycin on hypoxia-induced phosphorylation of Akt and mTOR, as well as expressions of HIF-1a, CTGF and collagen in SSc fibroblasts
Protein expressions of phospho-Akt (Thr308) (A1), phospho-Akt (Ser473) (A2) and phospho-mTOR (Ser2448) (A3) were determined by western blotting analysis after fibroblasts were cultured for 0, 10, 20 or 30 min. SSc fibroblasts were treated with 10 mM LY294002 and 50 nM rapamycin under hypoxic or normoxic condition for 24 h, and then expressions of phospho-Akt (Thr308) (B1), phospho-Akt (Ser473) (B2), phospho-mTOR (Ser2448) (B3), HIF-1a (B4 and C1), CTGF (B5 and C2) and collagen I (B6 and C3) were determined by western blotting analysis. Values are presented as mean (S.D.) (n *P < 0.05, **P < 0.01. hypoxia-induced Akt phosphorylation was through PI3K activation. LY294002 and rapamycin also down-regulated the HIF-1a expression under hypoxic condition (P < 0.01) and inhibited hypoxia-induced expressions of CTGF (P < 0.05) and collagen I (P < 0.05 or P < 0.01) [ Fig. 3 (B4)(B6), 3(C1)(C3)]. Fibroblasts from healthy controls showed similar results to SSc fibroblasts (data not shown). These results suggested that the PI3K/Akt/mTOR pathway was involved in the profibrotic effect of hypoxia in dermal fibroblasts.
Inhibitory effects of 2-ME on hypoxia-induced collagen synthesis of fibroblast Figure 4 shows that 2-ME ameliorated hypoxia-induced Akt and mTOR phosphorylation as well as expressions of HIF-1a, CTGF and collagen I in SSc fibroblasts. After 2-ME treatment under hypoxic conditions for 24 h, the phosphorylation of Akt at Thr308 (P < 0.01) and Ser473 (P < 0.05) and mTOR at Ser2448 (P < 0.05) were significantly down-regulated (Fig. 4AC) . Reduced expressions of HIF-1a, CTGF and collagen I were also observed (all P < 0.01) under hypoxic conditions (Fig. 4DF) . Fibroblasts from healthy controls showed similar results to SSc fibroblasts. Taken together, these results indicated that 2-ME inhibited the hypoxia-activated PI3K/Akt/mTOR pathway in SSc and normal fibroblasts.
Role of HIF-1a in hypoxia-induced fibrosis Figure 5 shows the effects of HIF-1a-knockdown on 2-ME-inhibited expressions of CTGF and collagen I in SSc fibroblasts under hypoxic condition. Compared with shCon-transfected cells, down-regulation of HIF-1a (P < 0.01) was detected in the shHIF-1a-transfected cells (Fig. 5A) . Compared with shCon-transfected cells, the protein levels of CTGF (Fig. 5B ) and collagen I (Fig. 5C ) were decreased in both shHIF-1a-transfected cells (P < 0.05 or P < 0.01) and 2-ME-treated shCon-transfected cells (P < 0.05 or P < 0.01). Additionally, shHIF1a-transfected cells treated with 2-ME presented the least expressions of CTGF and collagen I. Fibroblasts from healthy controls showed similar results to SSc fibroblasts. These results suggested that HIF-1a played a vital role in the inhibitory effect of 2-ME on hypoxia-induced fibrosis in both SSc and normal fibroblasts.
Inhibitory effects of 2-ME on cell proliferation and promotion of cell apoptosis
In the present study, we investigated the effects of 2-ME on apoptosis, cell cycle and proliferation of dermal fibroblasts. Figure 6A and B showed that there was no significant difference in apoptosis of SSc fibroblasts between hypoxic and normoxic conditions. However, 2-ME significantly increased the apoptosis of SSc fibroblasts cultured under hypoxic condition (P < 0.05). Figure 6C illustrates that 2-ME treatment resulted in a significant accumulation of G2 cells when cultured under hypoxic conditions (P < 0.05). Hypoxia increased cell growth rates of SSc fibroblasts compared with those cultured under normoxic conditions, mainly at 48 and 72 h (both P < 0.01) (Fig. 6D) . Moreover, 2-ME significantly inhibited the proliferation of SSc fibroblasts under hypoxic conditions at 24, 48 and 72 h (all P < 0.01) (Fig. 6D) . Fibroblasts from healthy controls showed similar results to SSc fibroblasts. These results indicated that 2-ME promoted the apoptosis of both SSc and normal fibroblasts, arrested the cells at the G2/M phase and inhibited the proliferation of these cells.
Discussion
In a previous study, we illustrated that 2-ME suppresses bleomycin-induced murine fibrosis by inhibiting the activation of SSc fibroblasts [11] , but the pathway through which 2-ME works remains largely unexplored. The results of this study indicated that PI3k/Akt/mTOR/HIF-1a signalling played an important role in the antifibrotic effect of 2-ME in SSc.
Distler et al. [14] have found that the fibrotic skins of SSc patients have apparently lower levels of intracutaneous PO 2 than the nonfibrotic skins and the skins of healthy volunteers. Herrick et al. [15] detected the hypoxic skins of patients with SSc by staining for hypoxic cell marker pimonidazole. However, the role of hypoxia in the pathogenesis of SSc remains elusive.
Proper oxygen homeostasis is crucial for cells, and cellular oxygen concentrations are fine-tuned to keep the supply of oxygen within the physiological range [16] . As a heterodimeric transcription factor, HIF-1 consists of an oxygen sensitive subunit a and a constitutively expressed subunit b [17] . The expression of HIF-1a is subtly controlled by cellular oxygen levels. In normoxia, HIF-1a is rapidly degraded after translation, but its expression is exponentially increased after exposure to low oxygen conditions. When both a and b subunits are bound, activated HIF-1 plays a crucial role in hypoxia-challenged cells through transcriptional activation of downstream genes involved in cell proliferation, angiogenesis and fibrogenesis [18] . Ioannou et al. [19] have detected potent expression of HIF-1a in the skin of SSc patients, while its expression is negative in skins of healthy controls. Our study found that HIF-1a was expressed not only in the fibrotic skins of SSc patients, but also in the skins of healthy controls. HIF1a expression exhibited a similar pattern in the epidermis of SSc patients and healthy controls, while more HIF-1a staining was detected in the dermis of SSc patients compared with healthy controls. We speculated that the higher expression of HIF-1a in the dermis of SSc patients might be attributed to pre-existing hypoxia in the fibrotic skin.
The progressive dermal fibrosis in SSc is associated with overexpression of profibrotic cytokines and over-production of collagen [20] . CTGF, a downstream cytokine of HIF-1a, is regarded as an important cytokine involved in the fibrosis of SSc [21] . Overexpression of CTGF is found in the serum of SSc patients and in cultured SSc skin fibroblasts [22] . CTGF is regarded as an upstream factor of collagen, which is significantly reduced in SSc and FIG. 4 Effects of 2-ME on hypoxia-induced Akt phosphorylation, HIF-1a, CTGF and collagen expressions in SSc fibroblasts Fibroblasts were treated with 25 mM 2-ME under hypoxic or normoxic condition for 24 h, and then the protein levels of phospho-Akt (Thr308) (A), phospho-Akt (Ser473) (B) , phospho-mTOR (Ser2448) (C), HIF-1a (D), CTGF (E) and collagen I (F) were determined by western blotting analysis. Values are presented as mean (S.D.) (n 5 3). *P < 0.05, **P < 0.01.
https://academic.oup.com/rheumatology normal fibroblasts by CTGF silencing [23] . Our present findings demonstrated that CTGF protein was located in the fibrotic lesions from SSc patients, while skin specimens from healthy volunteers showed no obvious CTGF staining. We found that hypoxia up-regulated the expressions of CTGF and collagen I through the activation of HIF-1a in dermal fibroblasts in a time-dependent manner.
It is known that PI3K/Akt/mTOR signalling axis is activated under hypoxic condition, and its activation is required for the hypoxic stabilization of HIF-1a [24] . PI3K is an important upstream regulator of hypoxia-induced Akt activation. Our results showed that the phosphorylation of Akt occurred at Ser473 and Thr308 positions and mTOR at Ser2448 position in SSc fibroblasts under hypoxic condition. Hypoxia-induced up-regulation of HIF-1a, CTGF and collagen I was significantly suppressed by PI3K inhibitor LY294002 and the classic mTOR inhibitor rapamycin in SSc fibroblasts, suggesting that PI3K/Akt/mTOR/ HIF-1a-mediated fibrogenesis was critically involved in the activation of SSc fibroblasts.
2-ME has been recognized as a well-tolerated antitumour agent in several clinical trials, and no grade-4 toxicity has been reported [10] . Recently, a great deal of attention has been paid to studies of 2-ME in CTDs. The anti-inflammatory and anti-angiogenic effects of 2-ME have been reported in several animal models [25, 26] . The antifibrotic effect of 2-ME has been reported in TGF-b3-induced profibrotic response in fibroid cells [27] . Moreover, 2-ME inhibited the vascular endothelial-tomesenchymal transition, and decreased the collagen deposition in radiation-induced lung fibrosis [28] . We were the first to report the anti-fibrotic effect of 2-ME in SSc [11] . In this study, we further demonstrated that 2-ME down-regulated the phosphorylation of Akt and mTOR and expressions of its downstream HIF-1a, CTGF and collagen I under hypoxic condition. HIF-1a silencing down-regulated the expressions of CTGF and collagen I, and synergistic effects were observed in shHIF-1a-transfected cells treated with 2-ME. These results suggested that PI3K/Akt/mTOR/HIF-1a was involved in the antifibrotic effect of 2-ME.
We then found that 2-ME attenuated the proliferation and accelerated the apoptosis of SSc fibroblasts cultured under hypoxic condition. Similar results have shown that 2-ME increases radiation-induced apoptosis of keloid fibroblasts and inhibits their proliferation in a dose-dependent manner [29] . However, the role of HIF1a in 2-ME-induced anti-proliferative and pro-apoptotic effects in dermal fibroblasts remains be clarified in further studies.
Taken together, our data provided evidence that 2-ME inhibited the fibrogenic effect of hypoxia on SSc fibroblasts by down-regulating CTGF and collagen I through the PI3K/Akt/mTOR/HIF-1a signalling pathway. In addition, 2-ME induced the apoptosis and inhibited the proliferation of SSc fibroblasts, which also in turn contributed to the anti-fibrogenic effect of 2-ME. Current findings shows that 2-ME may be used as a promising treatment for SSc and other fibrotic diseases.
FIG. 5 Effects of HIF-1a-knockdown on 2-ME-inhibited expressions of CTGF and collagen in SSc fibroblasts in hypoxia
Fibroblasts transfected with HIF-1a shRNA (shHIF) or control shRNA (shCon) were treated with 2-ME (25 mM) under hypoxic condition for 24 h. Expressions of HIF-1a (A), CTGF (B) and collagen I (C) were detected by western blotting analysis. Values are presented as mean (S.D.) (n 5 3). *P < 0.05, **P < 0.01. NC, normal control (untransfected fibroblasts).
